Evidence map›Paper›PMID 42143116›Full record

ArticleScientific reports2026

The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis.

Delphine Van Laethem, Lars Costers, Augusto Miravalle, Enrique Alvarez, Bennett Myers, Aaron Boster, Hanan Al Halawani, Maarten Dewil, Melissa Cambron, Matthias Grothe and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Delphine Van Laethem *AIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium. Delphine.Van.Laethem@vub.be.
Lars Costers *AIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium.
Augusto MiravalleRush University, Chicago, IL, USA.
Enrique AlvarezRocky Mountain Multiple Sclerosis Center, University of Colorado, Aurora, CO, USA.
Bennett MyersDENT Neurologic Institute, Amherst, NY, USA.
Aaron BosterThe Boster Center for Multiple Sclerosis, Columbus, OH, USA.
Hanan Al HalawaniTexas Neurology, Dallas, TX, USA.
Maarten DewilDepartment of Neurology, Imelda Hospital, Bonheiden, Belgium.
Melissa CambronAZ Sint-Jan Brugge, Brugge, Belgium.
Matthias GrotheUniversitätsmedizin Greifswald, Greifswald, Germany.
Stijn DenissenAIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium.
Rebecca Bartzicometrix, Leuven, Belgium.
Diana SimaAIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium.
Annemie Ribbensicometrix, Leuven, Belgium.
Dirk SmeetsAIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium.
Guy NagelsAIMS Lab, Vrije Universiteit Brussel/UZ Brussel, Brussels, Belgium.

Funding

CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking (JU) 101112153Fonds Wetenschappelijk Onderzoek 1SD5322N, 12A6U25N, 1805620NITEA grant from Flanders Innovation and Entrepreneurship. 20030 HeKDisco, HBC.2021.0500
6 · The paper itself

Abstract

Subjective cognitive performance in multiple sclerosis (MS) correlates weakly with objective performance, but is more strongly associated with depression. We aimed to identify symptoms and brain MRI volumes related to subjective and objective cognitive performance. 205 MS subjects, diagnosed within the last 15 years, completed the SymptoMScreen, patient-reported Expanded Disability Status Scale, Neuro-QoL subjective cognitive and fatigue sub-scores, and Beck Depression Inventory. For the objective cognitive assessment the smartphone-based icompanion Symbol test was used. Volumetric variables were calculated from the 52 available brain MRIs using icobrain. A weak correlation was observed between subjective and objective performance (rho = 0.21, p = 0.002). Subjective performance was negatively associated with pain, dizziness, fatigue and depression, while objective performance was negatively related to walking impairment. Objective performance significantly correlated with thalamic volume, while subjective performance did not correlate with any brain volumes. In other words, subjective and objective cognitive performance are related to different clinical markers: subjective performance is linked to invisible symptoms, while objective performance is linked to more visible measurable clinical markers. Integrating both perspectives in clinical practice may provide a more holistic understanding of cognition in MS, allowing for tailored interventions that enhance patient care and quality of life.

Indexed as

CognitionMagnetic Resonance ImagingMultiple SclerosisAdultBrainDepressionFatigueFemaleHumansMaleMiddle AgedQuality of Life

Identifiers

PMID42143116
PMCPMC13370009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.